ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Imaging techniques for evaluation of the painful joint

Imaging techniques for evaluation of the painful joint
Literature review current through: Jan 2024.
This topic last updated: Jul 27, 2022.

INTRODUCTION — Joint pain may be due to a broad array of conditions. Imaging studies of the joint, in combination with clinical and laboratory evaluation, are often helpful in establishing a specific diagnosis. The choice of imaging procedure is based upon the clinical situation, the differential diagnostic considerations, and the availability of specific imaging modalities. Guidelines for the use of musculoskeletal imaging for specific clinical situations are included among the American College of Radiology appropriateness criteria [1].

Sufficient history should be provided to assist the radiologist in study interpretation. Thus, the quality and location of pain, as well as any history of trauma, pertinent medical history, and laboratory data, are invaluable information when interpreting an imaging study [2].

An overview of the use of the diagnostic imaging modalities and techniques to evaluate joint pain is presented here. Detailed discussions of these techniques in specific diseases are presented separately (see appropriate topic reviews), as is the use of musculoskeletal ultrasound. (See "Musculoskeletal ultrasonography: Nomenclature, technical considerations, and basic principles of use" and "Musculoskeletal ultrasonography: Clinical applications" and "Musculoskeletal ultrasonography: Guided injection and aspiration of joints and related structures".)

RADIOGRAPHY — Radiography remains the initial imaging choice in many, if not most, bone and joint disorders. Radiography utilizes a radiograph tube with a two-dimensional image detector, a sheet of film, or digital detector. In most radiology departments, radiographic images are digital and thus are interpreted on a computer display.

Radiographs have the greatest resolution of all available imaging modalities. Densities that can be distinguished on radiographs are calcium, soft tissue, fat, and air. Radiography is especially useful for detecting and/or evaluating:

Fractures

Periosteal reaction

Soft tissue calcification or ossification

Localized lesions of bone

Orthopedic hardware

Bone dysplasias and other skeletal deformities

Two systems are available to produce digital projection radiographs, computed radiography and digital radiography. Computed radiography (CR) was introduced commercially in the early 1980s. In a CR system, a photostimulable storage phosphor screen or image plate acts as the detector that interacts with the x-rays, thus capturing a latent image; a laser light is used to stimulate the phosphor to luminesce, thus extracting the latent image from the screen and converting it into a digital image [3]. In CR, traditional film cassettes are replaced by storage phosphor cassettes, and chemical film processing is replaced by CR readers [3]. The images can be printed onto film or can be transmitted to a picture archiving and communication system (PACS) workstation.

Digital radiography (DR), introduced in the 1990s, refers to devices in which the digitization of the radiograph signal takes place within the detector itself via a photodiode and thin-film transistor (TFT) array [4]. This approach provides an immediate full-fidelity image on a display monitor. Detection devices can use either a direct or an indirect conversion mechanism.

Both CR and DR systems provide greater latitude than film screen systems and decrease the number of images that need to be repeated. The advantages of direct radiography include increased productivity and equivalent or better image quality at a potentially lower radiation dose to the patient [5,6]. Images are rapidly available for checking image quality and for interpretation, and systems can be networked for easy distribution of images.

The expense of installing CR or DR equipment is a disadvantage of digital radiography. DR systems coupled with a PACS allow images to be captured, stored, reviewed, interpreted, and distributed within minutes. DR systems are most often installed in high-volume areas, while CR systems can provide digital imaging to lower-volume areas at decreased expense and can provide a mechanism for capturing difficult examinations such as bedside "portables."

Regardless of which display method is used, a minimum of two radiographic projections at right angles are usually obtained to fully appreciate the area of interest, since abnormalities can potentially be obscured by superimposition. Standardized imaging protocols that may vary depending on clinical indication are used for most joints. Radiographic examination is relatively inexpensive, rapid, and nearly universally available.

Fluoroscopy — As a "real-time" radiographic imaging modality, fluoroscopy can be used to observe the motion of joints, to guide proper needle insertion into deep-seated joints, such as the hip or sacroiliac joint, and for intraoperative purposes [7]. It may also accurately detect focal cortical disease, fractures, and ligamentous instability, as the patient can be optimally positioned or a specific joint can be mechanically stressed under real-time imaging.

Arthrography — Generally, radiographic examinations show soft tissues (e.g. muscles, cartilage, joint fluid, menisci) to be the same density and therefore indistinguishable from one another. Arthrography refers to imaging following the injection of contrast material into a joint, and is often performed using fluoroscopic guidance. The injected contrast outlines intraarticular structures and differentiates them from adjacent soft tissues. It also distends the joint for better separation and visualization of structures [8,9].

Using sterile technique and local anesthesia, the joint space is entered with a needle. Synovial fluid may be aspirated for diagnostic purposes. Next, a contrast agent, such as iodinated contrast, is typically injected. Additionally, medication (eg, anesthetic and/or glucocorticoid) can be injected into the joint for therapeutic purposes as part of an arthrographic procedure.

Arthrography facilitates identification of intra-articular ("loose") bodies, certain ligament or tendon injuries, synovial or cartilage abnormalities, sinus tracts, and loosening of joint prostheses [10]. During the fluoroscopic portion of the examination, "real-time" tracking of contrast as it passes into and fills the joint can highlight abnormalities such as synovitis or abnormal contrast leakage. Arthrography can also be followed by computed tomography (CT; CT arthrography) or magnetic resonance imaging (MRI; MR arthrography, using a dilute gadolinium solution) for imaging. (See 'MR arthrography' below.)

Complications of arthrography are few, with the most common being synovial irritation (chemical synovitis) induced by the iodinated contrast agent, urticaria, and vasovagal reaction. Infection is rare [11,12].

Tomography — Conventional tomography uses reciprocal motion of the radiograph source and film about a fulcrum. This technique been replaced by CT.

Tomosynthesis — Tomosynthesis produces three-dimensional images by using several low-dose radiographs obtained at different angles. This technique, which has been used more commonly for breast imaging, has been applied to musculoskeletal problems including evaluation of fractures, hip prostheses, and rheumatoid arthritis (RA) [13,14]. A comparison of radiography, tomosynthesis, and MRI for the detection of erosion in a group of 20 consecutive patients with established RA found significantly more erosions with tomosynthesis and MRI than with radiography. Tomosynthesis was comparable to MRI with a sensitivity and specificity of 94.8 percent and 97.8 percent, respectively [13].

The radiation dose of tomosynthesis is lower than that of CT, and only slightly higher than that of radiography. A study comparing tomosynthesis with CT for the detection of erosions in the feet of RA patients reported a sensitivity and specificity for tomosynthesis of 80 and 75 percent, respectively [15]. Another study which evaluated tomosynthesis for the detection of hand and wrist erosions in RA patients found a sensitivity and specificity of 77.6 and 89.9 percent, respectively [16]. However, significantly more erosions were found with CT when compared with tomosynthesis, and significantly more erosions were found with tomosynthesis when compared with radiography.

COMPUTED TOMOGRAPHY — CT has become an important diagnostic aid in the evaluation of the musculoskeletal system. As examples, CT is extremely useful in detecting radiographically occult fractures of the acetabulum, cervical spine, wrist, and foot [17]. It is helpful in evaluating cortical destruction by metastatic lesions that may predispose to pathologic fracture. Ossific or calcific densities within a joint can be seen. Additionally, gas in soft tissues associated with necrotizing fasciitis can be detected, and newer techniques allow orthopedic hardware to be evaluated.

In CT utilizing a rotating radiograph source in the axial plane, attenuation values are processed by a computer to produce a cross-sectional image. Post-acquisition data processing allows for far greater latitude concerning image display compared with radiography. Equipment with a single linear array of detectors or with a two-dimensional array of multiple detectors (multidetector CT [MDCT]) may be used.

Helical CT involves continuous patient translation through the gantry at a constant rate during radiograph source rotation and data acquisition [18]. A volume set of data is, therefore, obtained in a relatively short period of time, often in a single breath hold. Helical CT results in decreased artifacts due to motion and respiratory misregistration. It also provides the capability for applications such as CT angiography [19].

MDCT allows thin sections to be obtained in shorter scan times. MDCT scanners using wide two‐dimensional
array detectors
allow large anatomical volumes to be imaged and reconstructed into thin overlapping sections in just a few seconds, facilitating oblique, multiplanar, and three-dimensional reconstructions.

Air-filled spaces, fatty tissue, muscle, and cortical and cancellous bone may all be evaluated with a single CT acquisition. Images may be displayed to best demonstrate soft tissues or bones. In contrast to radiography, complicated bony structures and complex pathological processes are displayed with clarity and without being obscured by superimposed structures.

Manipulation of the imaging data allows high-quality multiplanar reformations and three-dimensional displays to be created at a workstation or in a picture archiving and communication system (PACS). This is particularly useful in evaluating skeletal trauma, guiding surgical planning, and identifying relationships between structures and between fracture fragments [20].

Although the absolute resolution of CT is less than that of radiography, CT is superior in resolving subtle cortical disease. Small cortical or subchondral fractures and osteochondral intra-articular bodies are better seen on CT than on radiographs. CT has also been used to detect and calculate the volume of erosions in rheumatoid arthritis (RA) [21,22], and may be more accurate than MRI or ultrasound for the detection of bone erosions [23].

CT imaging also has benefits for certain indications compared with MRI. As an example, soft tissue calcifications and bony abnormalities are better characterized with CT, although MRI is superior for soft tissue contrast. Osteoid osteomas are usually better demonstrated on CT [24] (see "Nonmalignant bone lesions in children and adolescents", section on 'Osteoid osteoma'). The CT exam requires less time and tends to be less alarming to claustrophobic patients. Also, the presence of metallic implants or pacemakers and the use of life-support equipment do not preclude the use of CT, whereas some of these devices are contraindications to MRI. (See 'Contraindications to MRI' below.)

Technical advances and advanced image reconstruction methods have reduced the artifacts produced by metallic implants, so bone and soft tissue near hardware can be examined more easily [25,26]. In one series, retrospective evaluation of multidetector CT (MDCT) scanning for determining the presence of orthopedic hardware complications was performed in 109 patients (114 studies) [27]. Clinical or operative follow-up in 80 percent of cases provided the reference standard. The sensitivity and specificity of this imaging technique for detecting orthopedic hardware complications in patients with follow-up were 74 and 95 percent, respectively. CT was considerably better than radiography for the detection of these complications.

CT is frequently utilized for the purposes of guiding bone and soft tissue biopsy and aspiration procedures [28].

Dual-energy CT (DECT), in which an area is scanned simultaneously with two tubes at different energies (eg, 80 and 140 kVp), can be used to differentiate materials with similar CT numbers (related to the linear attenuation coefficient) such as iodine and bone [29]. Multiple techniques have been developed for acquiring dual-energy data. DECT can detect tophi and distinguish them from pseudogout and other soft tissue masses [30,31]. Pooled DECT sensitivity and specificity of 11 studies with a mean duration of gout of seven years were 0.87 (0.79 to 0.93) and 0.84 (0.75 to 0.90), respectively [32]. A prospective assessment of 40 patients with gout (mean duration 13 years, 88 percent of whom were on uric acid-lowering therapy) showed a sensitivity of 78 and 84 percent (depending on inclusion criteria) and a specificity of 93 percent [33]. The software algorithm used can significantly affect the positivity for urate [34]. The volume of tophi and subclinical tophi can be assessed using this method [35]. In one study, 15 percent of patients with asymptomatic hyperuricemia had subclinical monosodium urate crystal deposits on foot and ankle DECT scans [36]. However, the clinical significance of these subclinical deposits needs to be determined in a larger population. DECT has shown utility in gout evaluation of the musculoskeletal system identifying extraarticular or deep deposits not amenable to aspiration or other imaging [37]. Another study has shown high sensitivity of DECT for acute calcium pyrophosphate (CPP) crystal arthritis using synovial fluid crystal analysis as a reference standard, and further studies are in progress in this arena [38]. (See "Clinical manifestations and diagnosis of gout", section on 'Role of imaging in diagnosis'.)

Considerations for use — It is important to carefully review the indications for each CT examination and minimize the radiation dose as much as possible [39,40], particularly in children [41,42].

CT arthrography may be a substitute for patients who cannot have an MRI examination. CT arthrography of the knee, for example, may be used in patients with suspected internal derangement who cannot have MRI [43].

MAGNETIC RESONANCE IMAGING — MRI depicts internal structures based upon their chemical composition [44].

The principle of MRI is that, when a patient is placed in the bore of a super conducting electromagnet, free hydrogen nuclei within the tissues will align their inherent magnetic dipoles with that of the magnetic field. This creates a new atomic low-energy state. Rapid pulses of radio-frequency electromagnetic radiation are then imparted to the tissues, which deflect the spinning nuclei off their axes, creating a higher-energy state. As the nuclei return to their baseline state, they emit electromagnetic energy that varies in intensity based upon chemical composition. The energy released by the nuclei relaxing to their baseline energy level can be localized in space and can be quantified, and a cross-sectional image of the area can be produced. Anatomy-specific receiving coils that detect the released electromagnetic radiation are placed directly over the body part (joint) during scanning. A more detailed discussion of MRI is presented separately. (See "Principles of magnetic resonance imaging".)

Clinical MRI systems are available in several field strengths, usually ranging from 0.5 to 3 Tesla. Some advantages of higher field strength are increased signal to noise (providing higher spatial resolution), shorter image acquisition times, and improved imaging after intravenous contrast [45]. Whole body open-magnet systems provide greater ease in patient positioning, can be used for larger patients, and decrease claustrophobia. However, these magnets are often low- or mid-field with limited signal to noise [45].

Extremity magnets are often low-field magnets that are primarily designed for imaging of peripheral joints. Claustrophobia is avoided since only the part to be examined is placed within the magnet's bore. The use of low-field extremity magnets for imaging rheumatoid arthritis (RA) has been a topic of ongoing discussion, especially since these magnets are small enough to be located in an office or clinic [46].

Extremity MRI is more sensitive than radiography for the detection of joint erosions. This was illustrated in a study of 44 patients that revealed four times more erosions with extremity MRI than with radiography [47,48]. The authors of the study proposed that MRI of both hands could be used as a screening tool and that examining one hand could be used to monitor erosions over time.

Uses of MRI — A major advantage of MRI is its ability to evaluate noncalcified body tissues. For example, menisci, articular cartilage, cruciate ligaments, tendons, and joint fluid that would be indistinguishable on a radiograph are readily distinguished on MRI. Thus, MRI is particularly useful for the evaluation of soft tissue changes such as internal derangement, articular cartilage integrity, and synovitis. An infinite number of reconstruction planes allow for the sagittal, coronal, and axial displays of these complex structures. Normal tendons are completely black (low signal) on traditional MRI sequences. Tendons in early stages of degeneration demonstrate abnormal (increased) signal intensity and contour alterations, and complete disruptions are often readily identified.

MRI is also very sensitive in detecting subtle changes in the water content of tissues due to inflammation, neoplasm, trauma, or ischemia (see "Principles of magnetic resonance imaging"). Changes within the intramedullary canal of bone alter the normal marrow signal and are depicted with great clarity by MRI. Thus, conditions such as avascular necrosis, transient regional osteoporosis, early infections, subtle trauma, ischemia, and infiltrative processes are best visualized using MRI.

Contraindications to MRI — Each patient must be evaluated for both indications and contraindications to MRI. Several sources are available for reference regarding MRI safety [49] and contraindications to MRI including the American College of Radiology (ACR) website, www.mrisafety.com, and device or implant manufacturer information. The imaging provider can help evaluate for safety issues.

Examples of contraindications to MRI include the presence of [50]:

Orbital metallic foreign bodies

Most cardiac pacemakers – Some MRI conditional device implantable cardiac pacemakers may be scanned on a 1.5 T magnet with the pacemaker turned off during the time of the study, and the patient under the care of a cardiologist with monitoring, only after the case is deemed medically necessary by the radiologist and clinician and the appropriate risk-benefit analysis has been performed [51]

Implanted defibrillators

Most cochlear implants

Some aneurysm clips

MR-guided biopsy — Given the superior soft tissue contrast resolution inherent to MRI, it is not surprising that MR-guided biopsy has evolved as a tool to obtain tissue diagnosis for both bone and soft tissue lesions. With the use of special instrumentation, it has been found that MRI guidance is feasible for biopsies, spine procedures, cyst aspirations, therapeutic injections, and tumor ablation [52]. As MRI becomes increasingly available, it is likely that it will also become increasingly used for these purposes. By combining fluoroscopy with MRI to form hybrid systems, the advantages of each system can be utilized in a synergistic way [52].

MR arthrography — The administration of a dilute solution of gadolinium into a joint, followed by MRI, produces an MR arthrogram that allows the intraarticular structures (such as cartilage surfaces) to be better-defined and increases the ability to detect adjacent ligamentous or tendinous disruptions. MR arthrography is often used in evaluating the shoulder and the hip for labral tears. The gadolinium contrast agents that are available for use have generally not been explicitly approved for intra-articular injection by regulatory agencies in the US and Europe; thus, such use is "off-label" [53,54].

Indirect MR arthrography — After intravenous administration, gadolinium contrast material will diffuse into joints, even normal ones [55]. This diffusion can be utilized to provide an "indirect" or "intravenous" arthrogram, which can be helpful in delineating articular cartilage and other intraarticular structures. An increased rate of diffusion of contrast will occur in patients with active inflammatory arthritis. (See 'MRI uses in rheumatic disorders' below.)

Concerns expressed below regarding toxicity when used in patients with moderate to severe renal compromise also apply to intravenous MR arthrography. (See 'Potential gadolinium toxicity in renal failure' below.)

Intravenous contrast for MRI — Intravenously administered contrast agents, such as gadolinium, highlight vascular structures and may make some pathologic processes more conspicuous. MRI contrast agents reflect tissue vascularity and perfusion. In general, malignant soft tissue tumors show greater and more rapid contrast enhancement than benign lesions, although differentiation of benign from malignant lesions is limited [56]. Avascular, necrotic, and cystic areas will not show enhancement. Therefore, when there is a question of whether a lesion is solid or cystic, intravenous contrast can be helpful; this distinction can also be made with ultrasound. Intravenous contrast is also used in evaluating bone tumors.

Potential gadolinium toxicity in renal failure — Patients with moderately or severely impaired renal function (eg, estimated glomerular filtration rate of less than 30 mL/min) may need to avoid gadolinium-containing MRI contrast agents due to an enhanced risk of developing nephrogenic systemic fibrosis depending on the type of gadolinium agent/class used. The latest version of the ACR Manual on Contrast Media is a helpful resource for determining nephrogenic systemic fibrosis risk relative to the type of gadolinium agent used [57]. (See "Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced kidney disease", section on 'Prevention'.)

MRI uses in rheumatic disorders — The following areas are illustrative of some of the ways MRI can be used in the evaluation of rheumatic disease:

Osteoarthritis – MRI is generally not used for the diagnosis of OA, as clinical evaluation together with radiography appear to be the most effective methods for diagnosis, as indicated by a systematic review and meta-analysis of relevant studies [58]. The eventual role of MRI in the management of OA requires further clarification, and additional epidemiologic studies are needed [59]. MRI does demonstrate all of the structures that may be involved in OA, including the subchondral bone, articular cartilage, menisci, ligaments, and synovium. MRI is most often used as a research tool in OA, and several scoring systems have been developed for these purposes [60-62].

MRI may be used to quantify articular cartilage and to display it as a three-dimensional surface-rendered image [63]. In one study, cartilage volumes were evaluated in 107 OA patients at baseline, 12 months, and 24 months; determination of cartilage volume loss allowed identification of patients who were slow, intermediate, or fast progressors [64]. Clinical factors (such as a high body mass index) and morphological factors (such as severe meniscal extrusion) were predictors of rapid progression.

Cartilage repair – Orthopaedic techniques are being developed and refined to replace damaged articular cartilage. These procedures are especially used in the knee [65]. Techniques include microfracture, autografts and allografts, and autologous chondrocyte implantation (ACI), procedures described in some detail in the above reference [66-69]. While arthroscopy provides the gold standard for assessment of the repair, MRI can provide information about the fill of the defect, its integration, the signal intensity of the repair tissue, and the status of the subchondral bone in addition to assessing the remainder of the joint [65]. One study used delayed gadolinium-enhanced MRI (dGEMRIC) at 3Tesla to evaluate two groups of 10 patients each who had undergone ACI and microfracture, respectively [69]. At a mean time after surgery of 17 months, there was a statistically significant increase in the relative glycosaminoglycan (GAG) content within the ACI group as compared with the microfracture group [69]. (See "Overview of surgical therapy of knee and hip osteoarthritis".)

Rheumatoid arthritis – There is a lack of clarity regarding the indications for routine high-field MRI for the diagnosis and management of patients with RA [45,70]. A European Alliance of Associations for Rheumatology (EULAR; formerly known as European League Against Rheumatism) task force studied the role of MRI in RA in the clinical setting and their recommendations have been published [71]. Synovial hypertrophy, erosive disease, small subchondral cysts, and subchondral bone marrow edema not observed on radiographs can be visualized on MRI [72]. In one study of 31 patients with early RA who had swelling of the metacarpophalangeal joints, MRI detected bone marrow edema in 21 patients compared with 3 of 31 healthy control subjects. Synovial enhancement patterns can indicate active versus inactive RA. Bone marrow edema, synovitis, and erosion appear to be related, and, interestingly, bone marrow edema (osteitis) appears to be more predictive of erosion than is synovitis [73]. (See "Clinical manifestations of rheumatoid arthritis", section on 'MRI'.)

Sacroiliitis/spondyloarthritis – MRI of the sacroiliac (SI) joints is helpful for evaluating patients with clinically suspected sacroiliitis/spondyloarthritis with negative SI joint radiographs [74]. MRI can indicate the activity of disease with bone marrow edema/osteitis, synovitis, enthesitis, and capsulitis, suggesting active inflammation. Bone marrow edema/osteitis, in particular, has been thought to be essential for the diagnosis of active sacroiliitis [75]. Because bone marrow edema can be assessed without contrast administration, and because bone marrow edema always accompanies post contrast signs of inflammation (osteitis) [76], a noncontrast MRI with appropriate sequences (eg, short tau inversion recovery [STIR] and T1-weighted images) is usually sufficient to make a diagnosis of sacroiliitis and to quantify active inflammation [77]. However, some experts note that contrast may ensure maximum diagnostic confidence in patients with early sacroiliitis [77]. Erosion, sclerosis, fatty replacement of bone marrow, and fusion can also be evaluated. CT may be useful for diagnosis if radiographs are normal and MRI cannot be performed [74]. CT is best for identifying cortical erosive destruction and sclerosis and ankyloses that are more in keeping with previous inflammation [78]. Intravenous contrast is usually also not necessary for established sacroiliitis or for following disease [77]. MR evaluation of the early inflammatory changes of the vertebral body corner (Romanus lesions) within the spine is also useful in diagnosis of spondyloarthropathy, appearing as edema within the subchondral bone before true erosions occur [79]. (See "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'MRI of sacroiliac joints'.)

Gout – Radiography is the usual method for imaging the effects of gout, whereas dual-energy CT (DECT) scan has shown promise for detecting subclinical gout and evidence of gout not apparent on other imaging modalities (see 'Computed tomography' above). MRI findings in gout have been described but are not specific. Tophi appear as masses that demonstrate intermediate or low signal intensity on T1-weighted images and heterogeneous (or variable) signal intensity on T2-weighted or fluid-sensitive sequences [80,81]. Tophi can enhance heterogeneously after administration of intravenous contrast. Bone erosions adjacent to tophi produce cortical destruction but only mild to moderate bone marrow edema [80,82]. Marked amounts of bone marrow edema are suggestive of osteomyelitis in the correct clinical setting [82].

Other findings seen in gout are effusion and intratendinous tophi. In one study, MRI was 63 percent sensitive and 98 percent specific for the diagnosis of chronic gouty arthritis [83]. MRI may have advantages over ultrasound in that deeper structures can be assessed with MRI [80]. As noted above, patients with gout and osteomyelitis may be differentiated from those without osteomyelitis [82]. (See "Clinical manifestations and diagnosis of gout", section on 'Imaging'.)

Metallic arthroplasties – Technical advances have improved the quality of MRI around these prostheses so that osteolysis or fracture, the joint capsule synovitis, muscles, nerves, vessels, and tendons may be assessed [84,85]. In patients suspected of having complications associated with metal-on-metal prostheses, MRI is the imaging examination of choice [86,87]. (See "Complications of total hip arthroplasty", section on 'Sequelae from metal-on-metal wear debris'.)

Evaluation of 46 total knee prostheses (41 patients) using an MRI technique tailored to reduce metal susceptibility artifact resulted in surgical or other therapeutic procedures in 20 patients and influenced treatment in all patients [88].

NUCLEAR MEDICINE — Nuclear medicine uses the tracer principle. Scintigraphic images are produced following the administration of a radiopharmaceutical. The radiopharmaceutical distributes in the body based upon its chemical and biological properties. Radiation, mostly gamma photons, emitted from the agent is converted into planar or tomographic images. The unique aspect of scintigraphy is that radiotracer localization reflects molecular, metabolic, physiologic, and/or pathologic conditions of the body [89].

A number of nuclear imaging examinations have been used for evaluation of joint pain, including bone scan, labeled leukocyte scintigraphy (white blood cell [WBC] scan), gallium scan (using gallium-67 citrate), and positron emission tomography (PET), which is performed with 2-(fluorine-18) fluoro-2-deoxy-D-glucose (FDG) or fluorine-18 sodium fluoride (NaF). The type of scan depends upon the clinical indication. Of these examinations, the gallium scan will not be discussed as it is indicated primarily for evaluation of spondylodiscitis.

Bone scan — Bone scan is the most common nuclear imaging examination used to evaluate joint conditions. Bone scan may play a complementary role when other imaging studies are negative or inconclusive, but a strong clinical suspicion of bony abnormality remains. Technetium-99m (Tc-99m)-labeled diphosphonate, in the form of either methylene diphosphonate (MDP) or hydroxymethylene diphosphonate (HDP), is the most widely used bone scan tracer. Diphosphonate is adsorbed onto the surface of hydroxyapatite crystals. Increased bone uptake of this tracer mostly reflects increased bone turnover or remodeling in response to underlying processes (eg, infection, neoplasms, trauma, arthritis, etc). In the acute phase of infection or inflammation, increased tracer uptake is also due, in part, to increased blood flow, while the contribution of blood flow to bone uptake in chronic conditions is substantially less. Thus, greater acuity and severity of an inflammatory process generally results in findings of more increased blood flow and blood pool activity on the three-phase bone scan. However, the intensity on the delayed phase of the scan does not necessarily reflect the degree of inflammatory activity.

Bone scan is a highly sensitive technique for the detection of a large number of bone, joint, and periarticular disorders, including fracture, infection, tumor, arthritis, and metabolic bone disease [90]; thus, a negative study effectively excludes most bone and joint abnormalities. A finding of "increased tracer uptake" on a bone scan is nonspecific, although recognition of characteristic patterns of uptake and/or locations of involvement typical of different disease processes may provide more specific diagnostic information. Bone scan can also be useful for documenting the presence of arthritis and for assessing the extent and distribution of disease. Other studies, such as FDG-PET or labeled WBC scans, may be more suitable for assessing serial changes in inflammatory activity.

Bone scan findings and issues of importance in particular articular diseases include the following:

Osteoarthritis – Bone scan may show abnormal areas of uptake before radiography shows evidence of osteoarthritis (OA). While conventional bone scan is generally not performed for assessment of OA, some evidence suggests that single photon emission CT (SPECT or SPECT/CT) may play a role in the assessment of patients with OA:

SPECT or SPECT/CT findings are well-correlated with clinical findings, such as pain scores and physical examination in patients with knee OA.

SPECT or SPECT/CT is reported to be a sensitive tool for identifying early OA [91,92].

There is also a significant correlation between the intensity of uptake on SPECT-CT in the medial and lateral knee compartments and the varus or valgus alignment of the knee. In one study, SPECT-CT reflected the specific loading pattern of the knee with regard to its alignment and the severity of OA [93]. Thus, SPECT-CT could be used in the follow-up assessment of patients after realignment treatments or osteotomies, or it could be used with the use of deloader devices or insoles.

SPECT/CT improves the specificity; a considerable number of lesions initially thought to represent OA on conventional bone scan and SPECT were reclassified as fractures, or a number of lesions initially thought to represent osteomyelitis were reclassified as OA, fracture, or soft-tissue inflammation [94].

Rheumatoid arthritis – Bone scans generally are not used in the routine clinical management of rheumatoid arthritis (RA). However, a negative scan essentially excludes active RA in patients with persistent polyarthralgia because of the high sensitivity of bone scan for inflammatory joint disease [95]. Some observations in patients with RA include the following:

The distribution of tracer uptake may help distinguish seronegative arthritis from RA (eg, by demonstrating increased uptake in the distal interphalangeal joints in psoriatic arthritis versus in the metacarpophalangeal joints in RA).

Some studies but not others have suggested that erosions are most likely to develop in joints showing high tracer uptake, particularly when high activity persists [96,97]. One study suggested that bone scan could differentiate between early nonerosive RA and systemic lupus erythematosus (SLE) [98]. However, the uptake is nonspecific and not distinguishable from OA; thus, symptoms and location of specific joint involvement provide important clinical context.

Although the blood pool phase provides some information on the degree of inflammation, bone scan is generally not useful for assessing the level of activity of the arthritis, in part because it does not differentiate actively inflamed joints from chronically damaged ones [99,100].

In pediatric patients, it may be difficult to assess juvenile RA, particularly in the peripheral small joints, due to normally increased uptake in the adjacent growth plates.

Sacroiliitis – Bone scan has not become a widely used method for the evaluation of sacroiliitis because of its suboptimal specificity, although comparing the tracer uptake in the sacroiliac joints with a reference region, typically the sacrum, on a planar bone scan has been used to evaluate sacroiliitis. MRI has been found to be more accurate than quantitative planar bone scan in the detection of early sacroiliitis [101,102]. SPECT bone imaging together with MRI may provide complementary information. In one study, use of MRI and bone SPECT together provided objective and complementary evidence of sacroiliitis in patients with clinical features of inflammatory spinal disease in the absence of conventional radiographic changes [103].

Osteonecrosis (avascular necrosis) – Bone scans are not the diagnostic procedure of choice for diagnosing osteonecrosis. Bone scan of the hip typically shows decreased tracer uptake in the affected femoral head during the early stage of osteonecrosis, followed by variable degrees of increased uptake during the reparative stage. Osteonecrosis of the knee is typically associated with increased uptake regardless of the stage. In older female patients with acute knee pain who are suspected of having spontaneous osteonecrosis of the knee, intense tracer uptake in the medial femoral condyle is highly suggestive of the diagnosis. Osteonecrosis may also involve the lateral femoral condyle or the medial tibial plateau. (See "Clinical manifestations and diagnosis of osteonecrosis (avascular necrosis of bone)", section on 'Limited role of radionuclide bone scanning'.)

Painful joint replacement – A normal bone scan may be useful in the evaluation of patients with a painful joint replacement, as it is consistent with an absence of infection or other processes that may cause increased tracer activity around the hip or knee prosthesis; such findings on bone scan reflect increased bone mineral turnover and may result from any of a number of conditions in addition to infection. Additionally, there are numerous patterns of periprosthetic uptake associated with asymptomatic prostheses. However, the overall accuracy of conventional bone imaging in the evaluation of prosthesis complication (either infection or loosening) is about 50 to 70 percent, primarily due to poor specificity, and it is best used as a screening test. If the utility of conventional bone scan is to be maximized, it may be necessary to perform serial imaging, including baseline studies [104].

SPECT/CT is increasingly used for assessment of painful joint prosthesis replacement [105]. The technique is reported to be a promising tool for evaluation of post-knee arthroplasty pain, as the technique offers the combined analysis of tracer uptake distribution and intensity as well as the ability to measure prosthetic component position [106]. It may also identify the cause of pain in patients with unexplained pain after a metal on metal (MOM) total hip arthroplasty [107]. (See "Complications of total hip arthroplasty", section on 'Sequelae from metal-on-metal wear debris'.)

Labeled leukocyte scintigraphy — Labeled leukocyte scintigraphy (WBC scan) may be performed to evaluate for infectious processes such as osteomyelitis or an infected joint replacement. To perform a WBC scan, the patient's own white blood cells are labeled with either indium-111 or Tc-99m and are reinjected. (See "Approach to imaging modalities in the setting of suspected nonvertebral osteomyelitis", section on 'Nuclear modalities'.)

Increased WBC uptake around a painful joint replacement is a nonspecific finding. In patients with joint replacements, there is often reconversion of yellow marrow to red marrow. As labeled WBCs accumulate both in sites of infection and in red bone marrow, increased WBC uptake around joint replacements is, thus, not specific for infection. Distinguishing these two processes can be done by performing complementary WBC scanning and bone marrow imaging with Tc-99m-sulfur colloid. While both WBCs and sulfur colloid accumulate in red marrow, WBCs accumulate in infection, but sulfur colloid does not [108,109]. Therefore, increased activity on the labeled leukocyte images without corresponding activity on the sulfur colloid images is due to infection.

WBC scanning is not useful clinically in the management of RA, but it has been employed in research settings. In RA, labeled WBCs may accumulate in active inflammatory arthritis. In a study of 21 patients with RA, there was a significant correlation between the local manifestation of the active disease (swollen joint count) and the labeled leukocyte accumulation [110]. Another study suggested that semiquantitative values obtained with labeled WBC scan could distinguish active RA from inactive RA or osteoarthritis [111]. Labeled WBC accumulation has also been reported to be a sensitive index for monitoring RA activity in response to pharmacologic interventions, unlike quantitative bone scintigraphy [112].

PET scan — The most common clinical application of PET/CT is in oncology (eg, for staging known malignancies, monitoring the effect of treatment, and evaluation of tumor recurrence), followed by cardiology (eg, evaluation of ischemia, viability) and neurology (eg, differential diagnosis of dementia, Parkinson syndrome) [113]. While PET is not routinely used in the clinical evaluation of arthritis, it has been employed in the research setting.

PET is a diagnostic examination that involves the acquisition of physiologic images based upon the detection of two coincident gamma photons (positrons) traveling in opposite directions. These photons are generated from the annihilation of a positron with a native electron. Positron-emitting radionuclides are tagged to metabolically active pharmaceuticals and administered intravenously to the patient [114].

PET performed with FDG provides qualitative and quantitative metabolic information [113]. FDG is a radiopharmaceutical analogue of glucose that is taken up by metabolically active cells such as tumor cells [113].

PET and CT are separately performed, typically one immediately followed by the other on a hybrid PET/CT system. Generally, three sets of images, ie, PET images, CT images, and co-registered PET/CT images, are displayed on a viewing station. Metabolic activity of the area of interest is assessed both by visual inspection of the images and by measuring a semiquantitative value of FDG uptake, called standardized uptake value (SUV) [113].

A few examples of PET scan findings in specific diseases are as follows:

FDG-PET in rheumatoid arthritis – Since the FDG-PET studies showing increased FDG uptake in active RA were reported first in 1995 [115], many researchers have examined the utility of FDG-PET in patients with RA [115-122]. However, FDG-PET/CT is not routinely used in patients with RA in the United States.

Whole-body evaluation with FDG-PET/CT can detect the extent of disease activity, even at subclinical levels [117]. The sensitivity of FDG-PET for detecting inflamed joints in patients with RA is reported to be high (up to 90 percent) [116]. While healthy joints do not show abnormally increased FDG uptake, the presence of increased FDG uptake alone does not necessarily differentiate RA from other joint diseases such as OA or other inflammatory joint diseases [118,119]. However, biodistribution patterns of involved joints can be used to help distinguish among joint diseases [119].

Several studies have also shown a correlation between FDG uptake and other parameters of inflammation such as pannus formation on MRI [115], painful/swollen joints [116], and acute phase reactants [116]. In addition, early changes in FDG uptake in RA may predict clinical outcomes, as several reports have found that the changes in SUV in the inflamed joint correlate well with the clinical response assessed at various time points following treatment [115,120-122].

FDG-PET in prosthetic joint infection – FDG-PET is highly sensitive for the inflamed prosthetic joint. However, studies have demonstrated varied results of FDG-PET in diagnosing prosthetic joint infection, and its role has not yet been fully established [123,124]. (See "Prosthetic joint infection: Epidemiology, microbiology, clinical manifestations, and diagnosis", section on 'Radiographic imaging'.)

FDG-PET in spondylodiscitis – MRI is the gold standard for the diagnosis of discitis; however, FDG-PET is a useful adjunct to MRI and can be used when MRI is inconclusive or cannot be performed. Several investigations have shown that FDG-PET is highly sensitive and specific in the diagnosis of nontuberculous spondylodiscitis. One series of 38 patients with suspected spondylodiscitis with inconclusive results on conventional imaging reported sensitivity, specificity, and accuracy of FDG-PET/CT of 81.8, 100, and 89.5 percent, respectively [125]. Positive and negative predictive values were 100 and 80 percent, respectively [125,126]. Sensitivity, specificity, and accuracy of MRI performed on the same patients were 75, 71.4, and 74.1 percent, respectively [125]. FDG-PET also has utility in assessment of treatment response, as changes on MRI do not correlate with clinical response [126]. A prospective study including 30 patients with spinal infection found that the change in SUV max between the initial and the follow-up FDG-PET was the best predictor of residual infection [126,127].

FDG and fluoride PET in ankylosing spondylitis – Limited data suggest that ankylosing spondylitis (AS) activity is better reflected by bone activity on sodium fluoride PET/CT than inflammation on FDG-PET [128,129]. Additional studies are necessary to better define the role of each tracer in patients with AS.

ULTRASOUND — Ultrasonography (US), sometimes referred to as ultrasound imaging or sonography, is an imaging modality that utilizes reflected pulses of high-frequency (ultrasonic) sound waves. Musculoskeletal US can be used to assess soft tissues, cartilage, bone surfaces (cortical integrity), and fluid-containing structures and is becoming more widely available for diagnostic and therapeutic use in outpatient settings. US can be used clinically for assessing and monitoring inflammatory arthritis, for imaging tendons and bursae, and for guiding the aspiration and/or injection of joints or soft tissues.

Among the possible advantages of US are the avoidance of radiation exposure and of the inconvenience associated with use of fluoroscopy for procedures involving otherwise difficult-to-enter joints and other spaces. Limitations of US include poor soft tissue penetration of sound waves and their complete reflection by bone, resulting in limited acoustic windows for imaging joint pathology, as well as the substantial operator-dependence of US examination.

The clinical applications of musculoskeletal US, the technical aspects of musculoskeletal US, and the use of US imaging for joint, tendon, and bursal injections and for aspiration of fluid are addressed in detail separately. (See "Musculoskeletal ultrasonography: Clinical applications" and "Musculoskeletal ultrasonography: Nomenclature, technical considerations, and basic principles of use" and "Musculoskeletal ultrasonography: Guided injection and aspiration of joints and related structures".)

SUMMARY AND RECOMMENDATIONS

Radiographs are the imaging study of choice for routine evaluation of fractures, inflammatory and degenerative arthritides, metabolic bone disease, and developmental deformities. (See 'Radiography' above.)

CT may be useful in detecting cortical bony lesions and is widely used in fracture detection, especially in complex areas such as the cervical spine. Dual-energy CT (DECT) has shown utility in gout evaluation of the musculoskeletal system, identifying extraarticular or deep deposits not amenable to aspiration or other imaging. DECT has also shown utility in acute calcium pyrophosphate (CPP) crystal arthritis evaluation. (See 'Computed tomography' above.)

Internal derangement of a joint and soft tissue injuries are best evaluated with MRI. MRI can evaluate all of the tissues involved in osteoarthritis (OA) and can detect synovitis, erosion, and bone marrow edema (osteitis) in patients with rheumatoid arthritis. (See 'Magnetic resonance imaging' above.)

Nuclear medicine studies may play a complementary role when other imaging studies are negative or inconclusive but when there remains a strong clinical suspicion of bony abnormality. Positron emission tomography (PET) is an important modality for evaluating the metabolic activity of tumors and shows promise in the evaluation of arthritides as well, but its role in routine clinical practice has not been established. (See 'Nuclear medicine' above and 'Bone scan' above and 'PET scan' above.)

Musculoskeletal ultrasound (US) can be used to assess soft tissues, cartilage, bone surfaces, and fluid-containing structures. US can be used clinically for assessing and monitoring inflammatory arthritis, for imaging tendons and bursae, and for guiding the aspiration and/or injection of joints or soft tissues. (See 'Ultrasound' above.)

ACKNOWLEDGMENTS — The UpToDate editorial staff acknowledges Barbara N Weissman, MD, and Chun K Kim, MD, who contributed to an earlier version of this topic review.

  1. https://acsearch.acr.org/list (Accessed on November 12, 2015).
  2. Phillips AC, Polisson RP. The rational initial clinical evaluation of the patient with musculoskeletal complaints. Am J Med 1997; 103:7S.
  3. Gallet J, Titus H. CR/DR systems: what each technology offers today; what is expected for the future. Radiol Manage 2005; 27:30.
  4. Lanca L, Silva A. Digital radiography detectors – A technical overview: Part 1. Radiography 2009; 15:58.
  5. Reiner BI, Siegel EL, Hooper FJ, et al. Multi-institutional analysis of computed and direct radiography: part I. Technologist productivity. Radiology 2005; 236:413.
  6. Bacher K, Smeets P, Bonnarens K, et al. Dose reduction in patients undergoing chest imaging: digital amorphous silicon flat-panel detector radiography versus conventional film-screen radiography and phosphor-based computed radiography. AJR Am J Roentgenol 2003; 181:923.
  7. Choplin RH, Gilula LA, Murphy WA. Fluoroscopic evaluation of skeletal problems. Skeletal Radiol 1981; 7:191.
  8. Rhee RB, Chan KK, Lieu JG, et al. MR and CT arthrography of the shoulder. Semin Musculoskelet Radiol 2012; 16:3.
  9. Helgason JW, Chandnani VP, Yu JS. MR arthrography: a review of current technique and applications. AJR Am J Roentgenol 1997; 168:1473.
  10. Dalinka MK, Kricun ME, Zlatkin MB, Hibbard CA. Modern diagnostic imaging in joint disease. AJR Am J Roentgenol 1989; 152:229.
  11. Vollman AT, Craig JG, Hulen R, et al. Review of three magnetic resonance arthrography related infections. World J Radiol 2013; 5:41.
  12. Newberg AH, Munn CS, Robbins AH. Complications of arthrography. Radiology 1985; 155:605.
  13. Aoki T, Fujii M, Yamashita Y, et al. Tomosynthesis of the wrist and hand in patients with rheumatoid arthritis: comparison with radiography and MRI. AJR Am J Roentgenol 2014; 202:386.
  14. Göthlin JH, Geijer M. The utility of digital linear tomosynthesis imaging of total hip joint arthroplasty with suspicion of loosening: a prospective study in 40 patients. Biomed Res Int 2013; 2013:594631.
  15. Simoni P, Gérard L, Kaiser MJ, et al. Use of Tomosynthesis for Detection of Bone Erosions of the Foot in Patients With Established Rheumatoid Arthritis: Comparison With Radiography and CT. AJR Am J Roentgenol 2015; 205:364.
  16. Canella C, Philippe P, Pansini V, et al. Use of tomosynthesis for erosion evaluation in rheumatoid arthritic hands and wrists. Radiology 2011; 258:199.
  17. Geijer M, El-Khoury GY. Imaging of the acetabulum in the era of multidetector computed tomography. Emerg Radiol 2007; 14:271.
  18. Heiken JP, Brink JA, Vannier MW. Spiral (helical) CT. Radiology 1993; 189:647.
  19. Brink JA, Heiken JP, Wang G, et al. Helical CT: principles and technical considerations. Radiographics 1994; 14:887.
  20. Geijer M, El-Khoury GY. MDCT in the evaluation of skeletal trauma: principles, protocols, and clinical applications. Emerg Radiol 2006; 13:7.
  21. Duryea J, Magalnick M, Alli S, et al. Semiautomated three-dimensional segmentation software to quantify carpal bone volume changes on wrist CT scans for arthritis assessment. Med Phys 2008; 35:2321.
  22. Perry D, Stewart N, Benton N, et al. Detection of erosions in the rheumatoid hand; a comparative study of multidetector computerized tomography versus magnetic resonance scanning. J Rheumatol 2005; 32:256.
  23. Duryea J, Russell R, Gravallese EM, et al. Brief Report: Development and Validation of a Semiautomated Method to Measure Erosion Volume in Inflammatory Arthritis by Computed Tomography Scanning. Arthritis Rheumatol 2016; 68:332.
  24. Iyer RS, Chapman T, Chew FS. Pediatric bone imaging: diagnostic imaging of osteoid osteoma. AJR Am J Roentgenol 2012; 198:1039.
  25. Moon SG, Hong SH, Choi JY, et al. Metal artifact reduction by the alteration of technical factors in multidetector computed tomography: a 3-dimensional quantitative assessment. J Comput Assist Tomogr 2008; 32:630.
  26. Roth TD, Maertz NA, Parr JA, et al. CT of the hip prosthesis: appearance of components, fixation, and complications. Radiographics 2012; 32:1089.
  27. Ohashi K, El-Khoury GY, Bennett DL, et al. Orthopedic hardware complications diagnosed with multi-detector row CT. Radiology 2005; 237:570.
  28. Hau A, Kim I, Kattapuram S, et al. Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Skeletal Radiol 2002; 31:349.
  29. McCollough CH, Leng S, Yu L, Fletcher JG. Dual- and Multi-Energy CT: Principles, Technical Approaches, and Clinical Applications. Radiology 2015; 276:637.
  30. Mallinson PI, Coupal TM, McLaughlin PD, et al. Dual-Energy CT for the Musculoskeletal System. Radiology 2016; 281:690.
  31. Bongartz T, Glazebrook KN, Kavros SJ, et al. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis 2015; 74:1072.
  32. Ogdie A, Taylor WJ, Weatherall M, et al. Imaging modalities for the classification of gout: systematic literature review and meta-analysis. Ann Rheum Dis 2015; 74:1868.
  33. Choi HK, Burns LC, Shojania K, et al. Dual energy CT in gout: a prospective validation study. Ann Rheum Dis 2012; 71:1466.
  34. McQueen FM, Doyle AJ, Reeves Q, et al. DECT urate deposits: now you see them, now you don't. Ann Rheum Dis 2013; 72:458.
  35. Choi HK, Al-Arfaj AM, Eftekhari A, et al. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis 2009; 68:1609.
  36. Wang P, Smith SE, Garg R, et al. Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT. RMD Open 2018; 4:e000593.
  37. Nicolaou S, Liang T, Murphy DT, et al. Dual-energy CT: a promising new technique for assessment of the musculoskeletal system. AJR Am J Roentgenol 2012; 199:S78.
  38. Tedeschi SK, Solomon DH, Yoshida K, et al. A prospective study of dual-energy CT scanning, US and X-ray in acute calcium pyrophosphate crystal arthritis. Rheumatology (Oxford) 2020; 59:900.
  39. Wiest PW, Locken JA, Heintz PH, Mettler FA Jr. CT scanning: a major source of radiation exposure. Semin Ultrasound CT MR 2002; 23:402.
  40. Maldjian PD, Goldman AR. Reducing radiation dose in body CT: a primer on dose metrics and key CT technical parameters. AJR Am J Roentgenol 2013; 200:741.
  41. Frush DP, Donnelly LF, Rosen NS. Computed tomography and radiation risks: what pediatric health care providers should know. Pediatrics 2003; 112:951.
  42. Brody AS, Frush DP, Huda W, et al. Radiation risk to children from computed tomography. Pediatrics 2007; 120:677.
  43. Kalke RJ, Di Primio GA, Schweitzer ME. MR and CT arthrography of the knee. Semin Musculoskelet Radiol 2012; 16:57.
  44. Prost R, Czervionke LF. How does an MR scanner operate? AJNR Am J Neuroradiol 1994; 15:1383.
  45. American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force. Extremity magnetic resonance imaging in rheumatoid arthritis: report of the American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force. Arthritis Rheum 2006; 54:1034.
  46. Cohen SB, Potter H, Deodhar A, et al. Extremity magnetic resonance imaging in rheumatoid arthritis: Updated literature review. Arthritis Care Res (Hoboken) 2011; 63:660.
  47. Olech E, Freeston JE, Conaghan PG, et al. Using extremity magnetic resonance imaging to assess and monitor early rheumatoid arthritis: the optimal joint combination to be scanned in clinical practice. J Rheumatol 2008; 35:580.
  48. Mathew AJ, Bird P. Utility of in-office extremity magnetic resonance imaging in rheumatology. Ind J Rheumatol 2015; 10:140.
  49. Expert Panel on MR Safety, Kanal E, Barkovich AJ, et al. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging 2013; 37:501.
  50. Shellock FG, Morisoli S, Kanal E. MR procedures and biomedical implants, materials, and devices: 1993 update. Radiology 1993; 189:587.
  51. Strom JB, Whelan JB, Shen C, et al. Safety and utility of magnetic resonance imaging in patients with cardiac implantable electronic devices. Heart Rhythm 2017; 14:1138.
  52. Smith KA, Carrino JA. MRI-guided interventions of the musculoskeletal system. J Magn Reson Imaging 2008; 27:339.
  53. Thomsen HS. Recent hot topics in contrast media. Eur Radiol 2011; 21:492.
  54. Reimer P, Vosshenrich R. Off-label use of contrast agents. Eur Radiol 2008; 18:1096.
  55. Winalski CS, Aliabadi P, Wright RJ, et al. Enhancement of joint fluid with intravenously administered gadopentetate dimeglumine: technique, rationale, and implications. Radiology 1993; 187:179.
  56. Kransdorf MJ, Murphey MD. Soft tissue tumors: post-treatment imaging. Radiol Clin North Am 2006; 44:463.
  57. ACR Manual on Contrast Media – 2021 https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf (Accessed on June 09, 2022).
  58. Menashe L, Hirko K, Losina E, et al. The diagnostic performance of MRI in osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage 2012; 20:13.
  59. Conaghan P. Is MRI useful in osteoarthritis? Best Pract Res Clin Rheumatol 2006; 20:57.
  60. Hunter DJ, Lo GH, Gale D, et al. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis 2008; 67:206.
  61. Peterfy CG, Guermazi A, Zaim S, et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 2004; 12:177.
  62. Hunter DJ, Guermazi A, Lo GH, et al. Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score). Osteoarthritis Cartilage 2011; 19:990.
  63. McCauley TR, Disler DG. MR imaging of articular cartilage. Radiology 1998; 209:629.
  64. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis Res Ther 2006; 8:R21.
  65. Forney MC, Gupta A, Minas T, Winalski CS. Magnetic resonance imaging of cartilage repair procedures. Magn Reson Imaging Clin N Am 2014; 22:671.
  66. Knutsen G, Engebretsen L, Ludvigsen TC, et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 2004; 86-A:455.
  67. Tins BJ, McCall IW, Takahashi T, et al. Autologous chondrocyte implantation in knee joint: MR imaging and histologic features at 1-year follow-up. Radiology 2005; 234:501.
  68. Trattnig S, Winalski CS, Marlovits S, et al. Magnetic Resonance Imaging of Cartilage Repair: A Review. Cartilage 2011; 2:5.
  69. Trattnig S, Mamisch TC, Pinker K, et al. Differentiating normal hyaline cartilage from post-surgical repair tissue using fast gradient echo imaging in delayed gadolinium-enhanced MRI (dGEMRIC) at 3 Tesla. Eur Radiol 2008; 18:1251.
  70. Yazdany J, Schmajuk G, Robbins M, et al. Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question. Arthritis Care Res (Hoboken) 2013; 65:329.
  71. Colebatch AN, Edwards CJ, Østergaard M, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 2013; 72:804.
  72. Backhaus M, Kamradt T, Sandrock D, et al. Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum 1999; 42:1232.
  73. McQueen F, Naredo E. The 'disconnect' between synovitis and erosion in rheumatoid arthritis: a result of treatment or intrinsic to the disease process itself? Ann Rheum Dis 2011; 70:241.
  74. Mandl P, Navarro-Compán V, Terslev L, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 2015; 74:1327.
  75. Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009; 68:1520.
  76. de Hooge M, van den Berg R, Navarro-Compán V, et al. Magnetic resonance imaging of the sacroiliac joints in the early detection of spondyloarthritis: no added value of gadolinium compared with short tau inversion recovery sequence. Rheumatology (Oxford) 2013; 52:1220.
  77. Althoff CE, Feist E, Burova E, et al. Magnetic resonance imaging of active sacroiliitis: do we really need gadolinium? Eur J Radiol 2009; 71:232.
  78. Navallas M, Ares J, Beltrán B, et al. Sacroiliitis associated with axial spondyloarthropathy: new concepts and latest trends. Radiographics 2013; 33:933.
  79. Canella C, Schau B, Ribeiro E, et al. MRI in seronegative spondyloarthritis: imaging features and differential diagnosis in the spine and sacroiliac joints. AJR Am J Roentgenol 2013; 200:149.
  80. Girish G, Glazebrook KN, Jacobson JA. Advanced imaging in gout. AJR Am J Roentgenol 2013; 201:515.
  81. McQueen FM, Reeves Q, Dalbeth N. New insights into an old disease: advanced imaging in the diagnosis and management of gout. Postgrad Med J 2013; 89:87.
  82. Poh YJ, Dalbeth N, Doyle A, McQueen FM. Magnetic resonance imaging bone edema is not a major feature of gout unless there is concomitant osteomyelitis: 10-year findings from a high-prevalence population. J Rheumatol 2011; 38:2475.
  83. McQueen FM, Doyle A, Reeves Q, et al. Bone erosions in patients with chronic gouty arthropathy are associated with tophi but not bone oedema or synovitis: new insights from a 3 T MRI study. Rheumatology (Oxford) 2014; 53:95.
  84. Mistry A, Cahir J, Donell ST, et al. MRI of asymptomatic patients with metal-on-metal and polyethylene-on-metal total hip arthroplasties. Clin Radiol 2011; 66:540.
  85. Potter HG, Nestor BJ, Sofka CM, et al. Magnetic resonance imaging after total hip arthroplasty: evaluation of periprosthetic soft tissue. J Bone Joint Surg Am 2004; 86-A:1947.
  86. Ostlere S. How to image metal-on-metal prostheses and their complications. AJR Am J Roentgenol 2011; 197:558.
  87. Fritz J, Lurie B, Miller TT. Imaging of hip arthroplasty. Semin Musculoskelet Radiol 2013; 17:316.
  88. Sofka CM, Potter HG, Figgie M, Laskin R. Magnetic resonance imaging of total knee arthroplasty. Clin Orthop Relat Res 2003; :129.
  89. The American Board of Nuclear Medicine. www.abnm.org (Accessed on August 05, 2019).
  90. Bartel TB, Kuruva M, Gnanasegaran G, et al. SNMMI Procedure Standard for Bone Scintigraphy 4.0. J Nucl Med Technol 2018; 46:398.
  91. Kim HR, So Y, Moon SG, et al. Clinical value of (99m)Tc-methylene diphosphonate (MDP) bone single photon emission computed tomography (SPECT) in patients with knee osteoarthritis. Osteoarthritis Cartilage 2008; 16:212.
  92. Siebelt M, Agricola R, Weinans H, Kim YJ. The role of imaging in early hip OA. Osteoarthritis Cartilage 2014; 22:1470.
  93. Hirschmann MT, Schön S, Afifi FK, et al. Assessment of loading history of compartments in the knee using bone SPECT/CT: a study combining alignment and 99mTc-HDP tracer uptake/distribution patterns. J Orthop Res 2013; 31:268.
  94. Linke R, Kuwert T, Uder M, et al. Skeletal SPECT/CT of the peripheral extremities. AJR Am J Roentgenol 2010; 194:W329.
  95. Shearman J, Esdaile J, Hawkins D, Rosenthall L. Predictive value of radionuclide joint scintigrams. Arthritis Rheum 1982; 25:83.
  96. Möttönen TT, Hannonen P, Toivanen J, et al. Value of joint scintigraphy in the prediction of erosiveness in early rheumatoid arthritis. Ann Rheum Dis 1988; 47:183.
  97. Pitt P, Berry H, Clarke M, et al. Metabolic activity of erosions in rheumatoid arthritis. Ann Rheum Dis 1986; 45:235.
  98. Van de Wiele C, Van den Bosch F, Mielants H, et al. Bone scintigraphy of the hands in early stage lupus erythematosus and rheumatoid arthritis. J Rheumatol 1997; 24:1916.
  99. Berná L, Torres G, Diez C, et al. Technetium-99m human polyclonal immunoglobulin G studies and conventional bone scans to detect active joint inflammation in chronic rheumatoid arthritis. Eur J Nucl Med 1992; 19:173.
  100. de Bois MH, Arndt JW, van der Velde EA, et al. Joint scintigraphy for quantification of synovitis with 99mTc-labelled human immunoglobulin G compared to late phase scintigraphy with 99mTc-labelled diphosphonate. Br J Rheumatol 1994; 33:67.
  101. Battafarano DF, West SG, Rak KM, et al. Comparison of bone scan, computed tomography, and magnetic resonance imaging in the diagnosis of active sacroiliitis. Semin Arthritis Rheum 1993; 23:161.
  102. Blum U, Buitrago-Tellez C, Mundinger A, et al. Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI. J Rheumatol 1996; 23:2107.
  103. Hanly JG, Mitchell MJ, Barnes DC, MacMillan L. Early recognition of sacroiliitis by magnetic resonance imaging and single photon emission computed tomography. J Rheumatol 1994; 21:2088.
  104. Love C, Tomas MB, Marwin SE, et al. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001; 21:1229.
  105. Arıcan P, Okudan Tekin B, Şefizade R, et al. The role of bone SPECT/CT in the evaluation of painful joint prostheses. Nucl Med Commun 2015; 36:931.
  106. Hirschmann MT, Henckel J, Rasch H. SPECT/CT in patients with painful knee arthroplasty-what is the evidence? Skeletal Radiol 2013; 42:1201.
  107. Berber R, Henckel J, Khoo M, et al. Clinical Usefulness of SPECT-CT in Patients with an Unexplained Pain in Metal on Metal (MOM) Total Hip Arthroplasty. J Arthroplasty 2015; 30:687.
  108. Palestro CJ, Kim CK, Swyer AJ, et al. Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection. J Nucl Med 1990; 31:1950.
  109. Palestro CJ, Swyer AJ, Kim CK, Goldsmith SJ. Infected knee prosthesis: diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging. Radiology 1991; 179:645.
  110. Gaál J, Mézes A, Síró B, et al. 99m Tc-HMPAO labelled leukocyte scintigraphy in patients with rheumatoid arthritis: a comparison with disease activity. Nucl Med Commun 2002; 23:39.
  111. Uno K, Suguro T, Nohira K, et al. Comparison of Indium-111-labeled leukocyte scintigraphy and Technetium-99m joint scintigraphy in rheumatoid arthritis and osteoarthritis. Ann Nucl Med 1992; 6:247.
  112. al-Janabi MA, Sobnack R, Solanki KK, et al. The response of 99Tcm-methylene diphosphonate and 99Tcm-hexametazime-labelled neutrophils to intra-articular steroid injection in rheumatoid arthritis. Nucl Med Commun 1992; 13:528.
  113. Kapoor V, McCook BM, Torok FS. An introduction to PET-CT imaging. Radiographics 2004; 24:523.
  114. Mettler FA, Guiberteau MJ. Essentials of Nuclear Medicine Imaging, Saunders/Elsevier, Philadelphia 2006.
  115. Palmer WE, Rosenthal DI, Schoenberg OI, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995; 196:647.
  116. Beckers C, Jeukens X, Ribbens C, et al. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 2006; 33:275.
  117. Kubota K, Ito K, Morooka M, et al. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med 2009; 23:783.
  118. Hong YH, Kong EJ. (18F)Fluoro-deoxy-D-glucose uptake of knee joints in the aspect of age-related osteoarthritis: a case-control study. BMC Musculoskelet Disord 2013; 14:141.
  119. Okabe T, Shibata H, Shizukuishi K, et al. F-18 FDG uptake patterns and disease activity of collagen vascular diseases-associated arthritis. Clin Nucl Med 2011; 36:350.
  120. Roivainen A, Hautaniemi S, Mottonen T, et al. Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs. European journal of nuclear medicine and molecular imaging. Eur J Nucl Med Mol Imaging 2013; 40:403.
  121. Okamura K, Yonemoto Y, Arisaka Y, et al. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology (Oxford) 2012; 51:1484.
  122. Elzinga EH, van der Laken CJ, Comans EF, et al. 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study. J Nucl Med 2011; 52:77.
  123. Gemmel F, Van den Wyngaert H, Love C, et al. Prosthetic joint infections: radionuclide state-of-the-art imaging. Eur J Nucl Med Mol Imaging 2012; 39:892.
  124. Palestro CJ. Radionuclide Imaging of Musculoskeletal Infection: A Review. J Nucl Med 2016; 57:1406.
  125. Seifen T, Rettenbacher L, Thaler C, et al. Prolonged back pain attributed to suspected spondylodiscitis. The value of ¹⁸F-FDG PET/CT imaging in the diagnostic work-up of patients. Nuklearmedizin 2012; 51:194.
  126. Raghavan M, Lazzeri E, Palestro CJ. Imaging of Spondylodiscitis. Semin Nucl Med 2018; 48:131.
  127. Kim SJ, Kim IJ, Suh KT, et al. Prediction of residual disease of spine infection using F-18 FDG PET/CT. Spine (Phila Pa 1976) 2009; 34:2424.
  128. Bruijnen ST, van der Weijden MA, Klein JP, et al. Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study. Arthritis Res Ther 2012; 14:R71.
  129. Raynal M, Bouderraoui F, Ouichka R, et al. Performance of 18F-sodium fluoride positron emission tomography with computed tomography to assess inflammatory and structural sacroiliitis on magnetic resonance imaging and computed tomography, respectively, in axial spondyloarthritis. Arthritis Res Ther 2019; 21:119.
Topic 6921 Version 22.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟